Found 5 matching trials
RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma PHASE1 This phase I/II tests the safety, side effects, best dose and how well givi...
Show More Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy PHASE3 This study aims to determine the safety, pharmacokinetics (PK) and recommen...
Show More Location
Research Facility
Learn More & Join Trial
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs. PHASE1 Phase 1b/2 open-label trial of 225Ac-DOTATATE (RYZ101) in subjects with ER+...
Show More Status
Active Not Recruiting
Location
Research Facility
Learn More & Join Trial
A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors PHASE1 This study aims to determine the safety and the recommended phase II dose o...
Show More Location
Jules Bordet Institute
Learn More & Join Trial
Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC PHASE1 This study aims to determine the safety, preliminary antitumor activity, an...
Show More Status
Active Not Recruiting
Location
Research Facility
Learn More & Join Trial